Dimitra is an experienced biotech professional with deep knowledge of personalized medicine projects, therapeutics. medical devices, diagnostics, and Health IT.
Dimitra is a general partner of Qral Ventures, and serves as Chief Business Officer (CBO) in select portfolio companies. She is currently a member of the Innovation Faculty team for MIT’s LinQ Catalyst program, mentoring and guiding innovators solving health and medical challenges. Dimitra currently serves as a technical dilligence lead for the Keiretsu Forum Midwest Investments and a Venture Partner for MBx Capital (formerly FundRx), a next-generation of healthcare and life science venture capital firm. Dimitra serves as an advisor to the AIM-HI Accelerator Fund, a mentor for the mHUB MedTech Accelerator and mentor for the Polsky COMPASS program. Dimitra is also a Director at Large for Women in Bio {WIB}, responsible for the Executive Women in Bio Committee in Chicago, and on the board of National WIB, an organization dedicated to promoting careers, leadership, and entrepreneurship of women in the life sciences.
She was previously with Baxter International, where she was hired as the Innovation Scout, supporting late-stage technology scouting and tech assessment for due diligence M&A deals. Prior to that, she was the Director of Commercialization for Northwestern University’s Innovation and New Ventures Office, where she actively pursued innovation management, commercialization and funding strategies as well business development opportunities for inventors, ranging from start-up ventures to strategic partnerships, and established and directed an I-Corps like program called INVOForward. Before joining Northwestern, Dimitra was the VP of R&D of Ohmx Corporation, a diagnostic company with novel POC (point-of-care) technology and prior to that she worked for Nanosphere (now Luminex) and Inverness Medical (now Alere / Abbott), in novel biosensor development.
Dimitra earned a Ph.D. in Bioelectrochemistry from University College London (UCL), an M.Sc. in Biosensors from King’s College London; her post-doctoral work focused on nanoparticle based diagnostics. She is the author of numerous peer-reviewed publications and patents.